- Home
- ELWS vs CYCN Comparison
ELWS vs CYCN Comparison
Compare ELWS & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELWS
- CYCN
- Stock Information
- Founded
- ELWS 2018
- CYCN 2018
- Country
- ELWS Japan
- CYCN United States
- Employees
- ELWS N/A
- CYCN N/A
- Industry
- ELWS
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- ELWS
- CYCN Health Care
- Exchange
- ELWS Nasdaq
- CYCN Nasdaq
- Market Cap
- ELWS 6.1M
- CYCN 6.5M
- IPO Year
- ELWS 2023
- CYCN N/A
- Fundamental
- Price
- ELWS $1.83
- CYCN $3.07
- Analyst Decision
- ELWS
- CYCN
- Analyst Count
- ELWS 0
- CYCN 0
- Target Price
- ELWS N/A
- CYCN N/A
- AVG Volume (30 Days)
- ELWS 109.6K
- CYCN 20.6K
- Earning Date
- ELWS 07-07-2025
- CYCN 08-06-2025
- Dividend Yield
- ELWS N/A
- CYCN N/A
- EPS Growth
- ELWS N/A
- CYCN N/A
- EPS
- ELWS N/A
- CYCN N/A
- Revenue
- ELWS $2,292,406.00
- CYCN $2,081,000.00
- Revenue This Year
- ELWS N/A
- CYCN N/A
- Revenue Next Year
- ELWS N/A
- CYCN N/A
- P/E Ratio
- ELWS N/A
- CYCN N/A
- Revenue Growth
- ELWS 404.13
- CYCN N/A
- 52 Week Low
- ELWS $1.04
- CYCN $1.27
- 52 Week High
- ELWS $8.68
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- ELWS 31.96
- CYCN 45.97
- Support Level
- ELWS $1.85
- CYCN $3.02
- Resistance Level
- ELWS $2.16
- CYCN $3.22
- Average True Range (ATR)
- ELWS 0.10
- CYCN 0.23
- MACD
- ELWS -0.03
- CYCN -0.02
- Stochastic Oscillator
- ELWS 0.02
- CYCN 39.22
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.